Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
262.0000
2.30
(
0.89
%)
NSE
Jul 07, 2026
12:05 PM
New 52W High in past week
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
14 Mar 2024
262.00
0.89%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 301
Target
Ventura
Growth in demand and capabilities
Number of FII/FPI investors increased from 137 to 145 in Mar 2026 qtr.
More from Marksans Pharma Ltd.
All Rapid Results
Recommended
Market trades higher, Titan's revenue grows 41% YoY in Q1FY27
Trendlyne Marketwatch |
07 Jul 2026, 11:20AM
Primary market focus turns to listings, with eight companies set to debut
|
06 Jul 2026, 05:53PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017